NEW YORK, Aug. 24 – Shareholders of UK-based Gemini Genomics and US-based Sequenom have approved the firms’ plans to merge, the companies said on Thursday.

The combined company, which will retain the name Sequenom, must still obtain approval from the High Court of Justice in England and Wales. The companies anticipate the deal to close at the end of September.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.